158 related articles for article (PubMed ID: 23479396)
1. Predictive value of modelled tumour control probability based on individual measurements of in vitro radiosensitivity and potential doubling time.
Hedman M; Björk-Eriksson T; Brodin O; Toma-Dasu I
Br J Radiol; 2013 May; 86(1025):20130015. PubMed ID: 23479396
[TBL] [Abstract][Full Text] [Related]
2. Comparison of predicted and clinical response to radiotherapy: a radiobiology modelling study.
Hedman M; Bjork-Eriksson T; Mercke C; West C; Hesselius P; Brodin O
Acta Oncol; 2009; 48(4):584-90. PubMed ID: 19107620
[TBL] [Abstract][Full Text] [Related]
3. Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck.
Stausbøl-Grøn B; Overgaard J
Radiother Oncol; 1999 Jan; 50(1):47-55. PubMed ID: 10225557
[TBL] [Abstract][Full Text] [Related]
4. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
5. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
Guerrero M; Li XA
Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
[TBL] [Abstract][Full Text] [Related]
6. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone.
Gasinska A; Fowler JF; Lind BK; Urbanski K
Acta Oncol; 2004; 43(7):657-66. PubMed ID: 15545186
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric and radiobiological comparison of helical tomotherapy, forward-planned intensity-modulated radiotherapy and two-phase conformal plans for radical radiotherapy treatment of head and neck squamous cell carcinomas.
Chatterjee S; Willis N; Locks SM; Mott JH; Kelly CG
Br J Radiol; 2011 Dec; 84(1008):1083-90. PubMed ID: 22101580
[TBL] [Abstract][Full Text] [Related]
8. Impact of schedule duration on head and neck radiotherapy: accelerated tumor repopulation versus compensatory mucosal proliferation.
Fenwick JD; Pardo-Montero J; Nahum AE; Malik ZI
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):1021-30. PubMed ID: 21377280
[TBL] [Abstract][Full Text] [Related]
9. Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: a review of the Institute Gustave Roussy experience.
Eschwege F; Bourhis J; Girinski T; Lartigau E; Guichard M; Deblé D; Kepta L; Wilson GD; Luboinski B
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):849-53. PubMed ID: 9369133
[TBL] [Abstract][Full Text] [Related]
10. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
[TBL] [Abstract][Full Text] [Related]
11. Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy.
Her EJ; Reynolds HM; Mears C; Williams S; Moorehouse C; Millar JL; Ebert MA; Haworth A
Phys Med Biol; 2018 Jun; 63(13):135011. PubMed ID: 29799812
[TBL] [Abstract][Full Text] [Related]
12. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models.
Miksys N; Haidari M; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Med Phys; 2017 Aug; 44(8):4329-4340. PubMed ID: 28455849
[TBL] [Abstract][Full Text] [Related]
13. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Guenzi M; Margarino G; Bacigalupo A; Garaventa G; Barbieri M
J Clin Oncol; 1995 Aug; 13(8):1843-50. PubMed ID: 7636527
[TBL] [Abstract][Full Text] [Related]
14. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy].
Corvò R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Franzone P; Mereu P; Garaventa G; Barbieri M; Vitale V
Radiol Med; 1993; 86(1-2):135-42. PubMed ID: 8346344
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival.
Girinsky T; Lubin R; Pignon JP; Chavaudra N; Gazeau J; Dubray B; Cosset JM; Socie G; Fertil B
Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):3-7. PubMed ID: 8416879
[TBL] [Abstract][Full Text] [Related]
16. Steepness of the clinical dose-control curve and variation in the in vitro radiosensitivity of head and neck squamous cell carcinoma.
Bentzen SM
Int J Radiat Biol; 1992 Mar; 61(3):417-23. PubMed ID: 1347075
[TBL] [Abstract][Full Text] [Related]
17. Radiobiological characterization of head and neck and sarcoma cells derived from patients prior to radiotherapy.
Weichselbaum RR; Beckett MA; Vijayakumar S; Simon MA; Awan AM; Nachman J; Panje WR; Goldman ME; Tybor AG; Moran WJ
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):313-9. PubMed ID: 2394610
[TBL] [Abstract][Full Text] [Related]
18. Myths, facts and scope of spinal cord tolerance dose revision in Intensity modulated SIB treatment of locally advanced head and neck cancer: A dosimetrical and radiobiological demonstration.
Patel G; Mandal A; Choudhary S; Mishra R; Shahi U; Mishra H
Cancer Radiother; 2021 Feb; 25(1):8-12. PubMed ID: 33293203
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy.
Zackrisson B; Gustafsson H; Stenling R; Flygare P; Wilson GD
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):677-83. PubMed ID: 9240632
[TBL] [Abstract][Full Text] [Related]
20. Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma.
Pedicini P; Nappi A; Strigari L; Jereczek-Fossa BA; Alterio D; Cremonesi M; Botta F; Vischioni B; Caivano R; Fiorentino A; Improta G; Storto G; Benassi M; Orecchia R; Salvatore M
Radiat Oncol; 2012 Aug; 7():143. PubMed ID: 22920680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
